Company intelligence / Profile preview
APAC Biotech
Gurgaon, Haryana, Indiaapacbiotech.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
APAC Biotech's APCEDEN is the first India-approved dendritic cell-based cancer immunotherapy, with clinical data supporting an immune-activating, personalized approach for advanced cancer patients. It has received post-marketing study approval from Indian FDA and is expanding into brain cancer (GBM) and pancreatic cancer (PDAC) research[1][4].
- Therapeutic areas
- Oncology
- Modalities
- Dendritic cell therapyCell therapyBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Sir Ganga Ram Hospital (Delhi)Apollo Hospital Indraprastha (Delhi)Medanta Medicity Hospital (Gurugram)Ruby Hall Clinic (Pune)HCG Hospital (Bengaluru)Fortis Hospital (Mohali)Vrinchi Hospital (Hyderabad)Apollo Hospital (Hyderabad)Bhagwan Mahavir Hospital (Jaipur)
Beyond the preview
Go deeper on APAC Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APAC Biotech.